期刊文献+

环孢素A对骨髓增生异常综合征的干预评价

The Clinical evaluation of cyclosporina(CsA)on myelodysalastic syndrome
暂未订购
导出
摘要 目的 了解环孢素A(CsA)联合治疗骨髓增生异常综合征难治性贫血(MOS-RA)的疗效。方法:所有患者按CsA 3mg~5mg.kg^(-1).d^(-1)口服3~6个月,联合罗钙全,维生素B_6或加用达那唑、维甲酸。结果 所有病例的总有效率为71.4%,CR28.6%(2/7),PR42.8%(3/7),进步1例,无效1例。结论 CsA联合治疗MDS-RA是较有效的方法之一。 Objective To evaluate the clinical effects of cyclosporina (CaA) plus other medicines combined therapy on myelodysplastic syndrome refractory anemia(MDS-RA). Methods All the patients took CaA 3mg~5mg.kg~(- 1).d^(-1) for 3-6 months and other medicines such as Rocaltrol, vitaminB6 or Danasol, vitaminA acid. Results The overall response rate of all cases were 71.4%, the complete response rate (CR)were 28.6%(2/7), partial response rate (PR) were 42.8%(3/7), 1case made improvement. 1case made no difference. Conclusion CsA plus other medicines is one of the effective ways for MDS-RA.
出处 《海南医学》 CAS 2004年第6期42-42,77,共2页 Hainan Medical Journal
关键词 环孢素A CSA 骨髓增生异常综合征 MDS-RA 免疫抑制剂 myelodysplastic syndrome cyclosporine evaluate
  • 相关文献

参考文献5

  • 1徐世荣,郭晓楠.骨髓增生异常综合征的治疗[J].内科急危重症杂志,2000,6(1):41-43. 被引量:11
  • 2江志生,阎影.骨髓增生异常综合征淋巴细胞亚群分布[J].中华血液学杂志,1989,10(8):396-398. 被引量:2
  • 3Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematal, 2000,(2):131-133.
  • 4Jonasova A,Neuwirtova R,Cermak J,et al.CyclospoRin A theRapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow.Br J Haematol. 1998,100:304-309.
  • 5Hellstrom LE. Treatment of adult myelodysplastic syndromes. Int J Hematol 1999,70:141-154.

二级参考文献1

  • 1阎影,中国人民解放军军医进修学院学报,1986年,7卷,3期,251页

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部